{"disease":{"id":"primary-hypercholesterolemia","name":"primary hypercholesterolemia"},"drugs":{"marketed":[{"drug_id":"cholestyramine","indication_name":"Primary Hypercholesterolemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Questran Light","generic_name":"CHOLESTYRAMINE","company_name":"Bristol Myers","drug_phase":"marketed","molecular_target":"","drug_class":"Bile Acid Sequestrant [EPC]","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00479882","title":"MK-0524B Lipid Study (MK-0524B-063)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2414,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05559606","title":"An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe","phase":"","overall_status":"COMPLETED","enrollment_count":1839,"lead_sponsor_name":"Boryung Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT06770543","title":"Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT01274559","title":"Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1173,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01335997","title":"Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1139,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01294683","title":"A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":977,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05399992","title":"Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":847,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03882905","title":"A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":769,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT03464682","title":"Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":720,"lead_sponsor_name":"Zhejiang Hisun Pharmaceutical Co. Ltd.","has_results":false},{"nct_id":"NCT04849000","title":"Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":709,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT00941603","title":"Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":619,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07444086","title":"QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":510,"lead_sponsor_name":"Qilu Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04643093","title":"Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":390,"lead_sponsor_name":"Orient Pharma Co., Ltd.","has_results":false},{"nct_id":"NCT03413462","title":"Efficacy and Safety Study of HS-25 in Chinese Adults With Primary Hypercholesterolemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":374,"lead_sponsor_name":"Zhejiang Hisun Pharmaceutical Co. Ltd.","has_results":false},{"nct_id":"NCT05131997","title":"A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":290,"lead_sponsor_name":"Addpharma Inc.","has_results":false},{"nct_id":"NCT04584736","title":"To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":283,"lead_sponsor_name":"JW Pharmaceutical","has_results":false},{"nct_id":"NCT04652349","title":"Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":279,"lead_sponsor_name":"Hanmi Pharmaceutical Company Limited","has_results":false},{"nct_id":"NCT05206578","title":"Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":264,"lead_sponsor_name":"Ahn-Gook Pharmaceuticals Co.,Ltd","has_results":false},{"nct_id":"NCT03433755","title":"Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":259,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05888103","title":"Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07444762","title":"Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":184,"lead_sponsor_name":"Daewon Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06925100","title":"A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Daiichi Sankyo","has_results":false},{"nct_id":"NCT01879319","title":"Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04659070","title":"To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":156,"lead_sponsor_name":"Hanlim Pharm. Co., Ltd.","has_results":false},{"nct_id":"NCT06165250","title":"A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":156,"lead_sponsor_name":"Boryung Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT01849497","title":"Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05930028","title":"A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"Boryung Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT04844125","title":"SHR - 1209 Treatment Efficacy and Safety of the Patients With Hypercholesterolemia Ⅲ Period Clinical Research","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":144,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT00867165","title":"Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":138,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT00871351","title":"Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Organon and Co","has_results":true},{"nct_id":"NCT07391722","title":"DNV001 Injection in Patients With Hypercholesterolemia","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Hangzhou Dinovate Biotech Co., Ltd","has_results":false},{"nct_id":"NCT06448962","title":"Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"Addpharma Inc.","has_results":false},{"nct_id":"NCT05118230","title":"Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia","phase":"","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT06889012","title":"A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Boryung Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT06184269","title":"A Study to Evaluate the Pharmacokinetics and the Safety After Administration of \"BR1017-1\" and Co-administration of \"BR1017-1A\" and \"BR1017-1B\"","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Boryung Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT06475872","title":"Study to Evaluate the Bioequivalence of \"Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)\" and \"Crestor Tablet 5 mg (Rosuvastatin Calcium)\" in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Hanlim Pharm. Co., Ltd.","has_results":false},{"nct_id":"NCT06386419","title":"A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":32,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT05798390","title":"Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia Or Mixed Dyslipidemia","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company","has_results":false}],"total":38},"guidelines":[],"source":"Drug Landscape verified database"}